𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidation

✍ Scribed by David Hine; Bharti Mackness; Mike Mackness

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
93 KB
Volume
63
Category
Article
ISSN
1521-6543

No coin nor oath required. For personal study only.

✦ Synopsis

Therapeutic strategies to increase high-density lipoprotein (HDL) to treat or prevent vascular disease include the use of cholesteryl-ester transfer protein (CETP) inhibitors. Here, we show, to the best of our knowledge for the first time, that addition of CETP to HDL enhances the ability of HDL to inhibit low-density lipoprotein oxidation by ∼ 30% for total HDL and HDL(2) (both P < 0.05) and 75% for HDL(3) (P < 0.01). Therefore, CETP inhibition may be detrimental to the antiatherosclerotic properties of HDL, and these findings may partly explain the failure of the CETP inhibitor, torcetrapib, treatment to retard vascular disease despite large increases in HDL, in addition to its "off target" toxicity, a property which appears not to be shared by other members of this class of CETP inhibitor currently under clinical trial. Further, detailed studies are urgently required.

πŸ“œ SIMILAR VOLUMES

Cyclosporine A transfer between high- an
Cyclosporine A transfer between high- and low-density lipoproteins: Independent from lipid transfer protein I-facilitated transfer of lipoprotein-coated phospholipids because of high affinity of cyclosporine a for the protein component of lipoproteins
✍ Mona Kwong; Olena Sivak; Evan H. Kwong; Kishor M. Wasan πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 126 KB

The objectives of this study were to determine if lipid transfer protein I (LTP I)-facilitated phospholipid (PC) transfer activity regulates the plasma lipoprotein distribution of cyclosporine (CSA) and if the association of CSA with high-density lipoproteins (HDL) is due to the high protein and/or

Genistein- and daidzein 7-O-Ξ²-D-glucuron
Genistein- and daidzein 7-O-Ξ²-D-glucuronic acid retain the ability to inhibit copper-mediated lipid oxidation of low density lipoprotein
✍ Tiny Kgomotso; Francis Chiu; Ken Ng πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 635 KB

## Abstract Two isoflavones __in vivo__ metabolites, genistein‐7‐__O__‐β‐D‐glucuronic acid (G7G) and daidzein‐7‐__O__‐β‐D‐glucuronic acid (D7G) were synthesised chemically. The ability of these metabolites to scavenge an organic radical was measured by the trolox equivalent antioxidant capacity (TE

Contribution of HDL-apolipoproteins to t
Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages
✍ Kae-Yuan Lin; Yuh-Lien Chen; Chun-Che Shih; Ju-Pin Pan; Woan-Eng Chan; An-Na Chi πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 318 KB

High-density lipoprotein (HDL) is known as a protective factor against atherosclerosis. However, whether HDL-apolipoproteins (apo-HDL) contribute to the protection in arterial cells remains unclear. The localization patterns of human apolipoproteins in atherosclerotic arteries were determined using

Decrease of hepatic triglyceride lipase
Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: Relationship to abnormalities in high-density lipoprotein
✍ Dr. Hisatoyo Hiraoka; Shizuya Yamashita; Yuji Matsuzawa; Masaharu Kubo; Shuichi πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 937 KB

Serum levels of high-density lipoprotein cholesterol are often increased in patients with primary biliary cirrhosis. To elucidate the mechanism of the elevation of high-density lipoprotein cholesterol levels in this disease, lipoprotein abnormalities were analyzed in 10 patients subdivided into two